P - Caution when used during pregnancy
L - Caution when used during lactation
LI - Lab *
Sulfacetamide is a sulfonamide antibiotic.
Sulfacetamide has bacteriostatic effect on a wide range of gram-positive and gram-negative organisms. It interferes with nucleic acid synthesis thus blocking conversion of PABA to the coenzyme dihydrofolic acid.
Absorption
Penetrates into ocular tissues and fluids (ophthalmic).
Excretion
Urine (as unchanged drug); 7-13 hours (elimination half-life).
Information Not Available
Hypersensitivity skin reaction. Ophthalmic: Burning, stinging, conjunctivitis, corneal ulcers, irritation, conjunctival hyperaemia. Systemic absorption from inflamed conjunctiva.
Potentially Fatal: Stevens-Johnson syndrome.
Prolonged use of topical anti-bacterial agents may give rise to overgrowth of nonsusceptible organisms including fungi. Bacterial resistance to sulfonamides may also develop.
Elderly. History of allergy or asthma; G6PD deficiency; renal and hepatic impairment. Prolonged therapy requires CBC and urinalysis with microscopic examination. Maintain adequate fluid intake. Pregnancy, lactation.
Action antagonised by PABA and procaine group of local anaesthetics. PABA present in purulent eye exudates can competitively inhibit the action of sulphacetamide.
Information Not Available
Ophthalmic
Ocular infections
Adult: As sodium: Apply 10-30% eye drops or 10% ointment into the affected eye/s. May be used up to tid.
Information Not Available
Caution when used during pregnancy
Caution when used during lactation
Information Not Available
Information Not Available
Hypersensitivity; infants <2 months
Ophthalmic
Store below 25°C.
Ophthalmic
Store below 25°C.
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.